Status:
UNKNOWN
Ambulatory SNP Under Local Anaesthesia in a Subgroup of Breast Cancer Patients - Trial
Lead Sponsor:
Medical Center Alkmaar
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
Rationale: In breast cancer (BC) patients, lymph node status is a key prognostic indicator. At present, axillary ultrasound (US) with subsequent fine needle aspiration cytology (FNAC) of suspicious ly...
Eligibility Criteria
Inclusion
- Female
- Age 18-60 years
- Diagnosis of invasive BC (established with core needle biopsy of the breast lesion)
- Breast carcinoma measures \> 20 mm ultrasonographically
- Pre-operative US+FNAC is negative or inconclusive
- No evidence of distant metastases
- ASA Classification I-III
- Signed informed consent
Exclusion
- History of previous breast surgery in the affected breast
- History of previous axillary surgery in the ipsilateral axilla
- History of radiation therapy (ipsilateral breast or axilla)
- History of neo-adjuvant therapy (for the BC)
- Known allergy to lidocain
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2017
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02187718
Start Date
January 1 2015
End Date
August 1 2017
Last Update
July 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Center Alkmaar
Alkmaar, North Holland, Netherlands